Category- Allopathy
Medicine Highlights
| Uses | 1. To manage type 2 Diabetes mellitus 2. To treat nonalcoholic fatty liver disease |
| Common Side Effects | 1. Thirst 2. Dizziness 3. Candidiasis (genital fungal infections) 4. Fatigue 5. Increased Urine |
| Additional Information | 1. Take 15 to 30 minutes before meals to get maximum effect. 2. It is not recommended to use it without a prescription. |
| Storage | 1. The medicine should be stored at room temperature. 2. Keep away from sunlight and moisture. 3. Keep away from the reach of children |
| How to Take This Medicine | Take this medication orally with a sip of water. |
Remogliflozin Etabonate Uses
Remogliflozin etabonate 100 mg is an oral medicine belonging to the category of antidiabetic drugs and is used for the following indications:
- Type 2 Diabetes mellitus
- Nonalcoholic fatty liver disease
Remogliflozin Etabonate side effects
More Common
- Thirst
- Dizziness
- Candidiasis (genital fungal infections)
- Fatigue
- Increased Urine
Less Common
- Low blood sugar
- Burning or pain while peeing
- Itchy skin
- Skin rash
- Serious acid build-up in the body (ketoacidosis)
How Remogliflozin Etabonate works
Remogliflozin work by stopping the kidneys from depositing sugar into the blood. Instead, it acts like a smart filter that lets excess sugar leave the body through urine, which naturally lowers blood sugar levels.
Safety Measures and Warning
Pregnancy
Due to a lack of studies on the effects of Remogliflozin Etabonate on the fetus during pregnancy, its safety is not clearly established. Therefore, if you are pregnant or planning to conceive, inform your doctor.
Breastfeeding
Remogliflozin etabonate passes into breast milk. Tell your healthcare provider if you are breastfeeding or plan to breastfeed. Your healthcare provider will advise you if you should stop breastfeeding or stop remogliflozin etabonate
Kidney and Liver Problems
Patients suffering from kidney and liver problems are more prone to kidney and liver damage, as the drug is made into a less toxic form in the liver and kidney, so consult a doctor before using them.
Remogliflozin Etabonate Interaction with Food Product
Alcohol and smoking can simultaneously affect the drug’s action and show an effect on blood glucose levels by affecting the liver and pancreas. It can sometimes increase blood sugar levels and sometimes decrease blood sugar levels.
Remogliflozin Etabonate Interaction with Other Medicines
Avoid taking Remogliflozin Etabonate 100 mg with the following medicines, as it may increase or decrease the desired effect, or in worse cases, it could be fatal:
Remogliflozin Etabonate Chemical Structure
IUPAC (International Union of Pure and Applied Chemistry)/ Chemical name
5-Methyl -4-[4-(1-methylethoxy) benzyl] -1-(1-methylethyl) -1H-pyrazol-3-yl 6-O-(ethoxy carbonyl)-β-D-glucopyranoside

Intake routine/cycle
Daily dose
Take Remogliflozin Etabonate exactly as your doctor recommends. The dose may change based on your condition and how well you respond. Do not take more than prescribed without consulting your doctor.
Missed Dose
If you forget to take your medicine, take the medication as soon as you remember. If it’s nearly time for your next dose, skip the missed one and continue with your regular schedule. Always consult the doctor before making any changes to your dosage.
Overdose
It is not recommended to take more than 200 mg of Remogliflozin etabonate per day, as it may cause severe overdosing effects like extreme drowsiness, confusion, low blood pressure, unconsciousness, sweating, gastric symptoms, and seizures. Immediately give the patient fruit or glucose-containing liquids and sugary foods to minimize the effects. If you face any of the severe effects, meet the doctor.
Storage
- Store the medicine at room temperature.
- Keep away from sunlight and moisture.
- Keep out of reach of children.
Directions for use
- Take Remogliflozin Etabonate exactly as prescribed by your doctor, at the same time each day.
- Do not stop taking Remogliflozin Etabonate without your doctor’s approval, even if you feel better.
- If you forget to take Remogliflozin Etabonate, take it as soon as you remember. If it’s almost time for your next dose, skip the missed dose.
Remogliflozin Etabonate Summary
Remogliflozin etabonate is an oral antidiabetic drug from the SGLT2 (Sodium-Glucose Co-Transporter 2) inhibitor class, used to manage type 2 diabetes by blocking glucose reabsorption in the kidneys and promoting its excretion through urine . It’s especially helpful in overweight patients. Common side effects of this medicine include increased urination, genital infections, dehydration, and dizziness. It can be taken before or after food, though high-fat meals may slightly delay absorption; alcohol and low-carb diets should be approached cautiously due to heightened risks of dehydration and ketoacidosis.
FAQ’s
What are the uses of remogliflozin etabonate 100 mg?
Remogliflozin etabonate is used to lower blood sugar levels in adults with type 2 diabetes, especially when diet and exercise alone aren’t enough. It may also support weight loss and reduce blood pressure as added benefits.
What is the drug class of remogliflozin etabonate medication?
Remogliflozin etabonate belongs to the class of SGLT2 inhibitors (Sodium-Glucose Co-Transporter 2 inhibitors). These drugs help lower blood sugar by preventing glucose reabsorption in the kidneys, promoting its excretion through urine.
What is the mechanism of action of the Remogliflozin Etabonate tablet?
Remogliflozin etabonate lowers blood sugar by blocking kidney sugar channels (SGLT2), causing excess glucose to be passed out through urine.
Can Remogliflozin Etabonate cause weight loss?
Yes, remogliflozin etabonate can lead to modest weight loss by promoting sugar loss through urine, which reduces calorie load. This effect is especially helpful in overweight individuals with type 2 diabetes.
Reference
- Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389(10085):2239–51. Available from.
- Drug Bank Online. Remogliflozin etabonate [Internet]. Edmonton (AB): Drug Bank; 2021 [cited 2025 Sep 25]. Available from.
- PubChem. Remogliflozin etabonate [Internet]. Bethesda (MD): National Library of Medicine (US); [cited 2025 Sep 25]. Available from.
- Medical Dialogues. Remogliflozin etabonate [Internet]. New Delhi: Medical Dialogues; [cited 2025 Sep 25]. Available from.

Siva Krishna Adithya Bhumireddy completed a Bachelor of Pharmacy from GIET School of Pharmacy, affiliated with Andhra University, and from his 3rd year of graduation, he was working as a freelance medical and publication writer. Having expertise in systematic reviews and clinical research. With his keen interest and skills in research and documentation practices, he also reviewed more than 150 manuscripts from international journals like Elsevier, Springer Nature, and Sage Journals, and all the manuscripts were indexed and appeared in PubMed, Scopus, and Web of Science databases, and he received honorary recognition letters and certificates from all of them. Siva Krishna Adithya also published a few systematic, narrative reviews and a few chapters of international expertise.